Atlas Trials

Safety and Efficacy of Mucinex and IR Guaifenesin the Treatment of Symptoms of Acute Upper Respiratory Tract Infections

Clinical trial NCT01537081 · COMPLETED

Trial details

NCT number
NCT01537081
Sponsor
Reckitt Benckiser LLC
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute Upper Respiratory Tract Infection
Start date
2011-09-01
Primary completion
2012-03-01
Enrollment
2810

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.